<unk> (nasal) is an endocrine metabolic agent that is FDA approved for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause when alternative treatments are not suitable.   Common adverse reactions include rhinitis, epistaxis, back pain, arthralgia, and headache..
Calcitonin 
Parathyroid hormone 
Calcitriol 
Thyroid hormone
Procalcitonin
Reverse triiodothyronine
Estradiol 
Testosterone 